Phase 4
N=468
Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF)
Infertility
Bottom Line
View on ClinicalTrials.gov: NCT00656201 ↗Enrolled (actual)
468
Serious AEs
0.0%
Results posted
Sep 2011
Primary outcome: Primary: Percentage of Pregnant Patients After IVF Treatments — 66; 62 percentage of participants — p=<0.05
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Crinone 8% Vaginal Gel (Drug); Intramuscular Progesterone (Drug)
- Age
- Adult · 21+ yrs
- Sex
- Female
- Sponsor
- Brigham and Women's Hospital
- Primary completion
- Nov 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Pregnant Patients After IVF Treatments |
66; 62 | <0.05 sig |
Summary
The goal of this research study is to compare the pregnancy rates for two different types of progesterone supplementation after in-vitro fertilization (IVF).
Eligibility Criteria
Inclusion Criteria
- Women of reproductive age (21-39) with infertility who are appropriate candidates for IVF/ET and have an FSH < 15 mIU/ml
- Women 21 to 39 years of age who have been assigned to stimulation of 2 to 8 amps of Luteal Lupron/FSH or Luteal Lupron FSH/HMG.
Exclusion Criteria
- Women who have had more than 3 previous IVF/ET cycles
Data sourced from ClinicalTrials.gov (NCT00656201). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.